Robert Bradway, Chairman and CEO of Amgen
Keynote speaker at MIT LGO conference on "The Future of Manufacturing in the U.S." (May 8, 2012)
Scientists are working to develop new medicines for some of the world’s greatest health challenges. For biotechnology medicines, innovation extends from discovery and development into manufacturing. Developing new ways to manufacture complex proteins, monoclonal antibodies and peptibodies on a commercial scale is a critical step in delivering on the promise of biotechnology for patients. This talk will explore what it takes to thrive in an increasingly complex, competitive and highly regulated industry.